Global Pharma NewsPharma NewsPharma Suchana

Top Pharma News Updates- Glenmark, Lupin, Intas Pharma, Amneal Pharma & Biological E. Limited (BE)

ADMIN
ADMIN

Top Pharma News Updates- Glenmark, Lupin, Intas Pharma, Amneal Pharma & Biological E. Limited (BE)

1 ) Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg.

2 ) Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region

3 ) Lupin gets USFDA approval for Sildenafil Oral Suspension, 10mg/mL

4 ) Amneal Pharmaceuticals Awarded a Sub-License from MPP to Manufacture and Commercialize Generic Version of Co-Packaged Nirmatrelvir and Ritonavir.

5 ) Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar in the Middle East.

6 ) BE TO GET mRNA TECH FROM WHO TO PRODUCE COVID-19 VACCINES.

WhatsApp Group Join Now
Telegram Group Join Now
- Advertisement -
DEFINE ACADEMY DRUG REGULATORY AFFAIRSDEFINE ACADEMY DRUG REGULATORY AFFAIRS
Share This Article
Previous Article Sun Pharmaceutical Industries Walk-in Interview on 10th April 2022, Sunday
Next Article Aurobindo Pharma Ltd Walk-in Interview for Production department on 09.04.2022
JOIN WHATSAPP CHANNEL
JOIN OUR WHATSAPP GROUP
JOIN OUR TELEGRAM GROUP
Verified by MonsterInsights